Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study (Q34093139)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

1 reference

based on heuristic

inferred from title

acute coronary syndrome

1 reference

based on heuristic

inferred from title

Philippe Gabriel Steg

13

object named as

Philippe Gabriel Steg

0 references

Robert F. Storey

object named as

Robert F Storey

14

0 references

16

object named as

Lars Wallentin

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Robert A Harrington

2

object named as

Robert A Harrington

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Håkan Emanuelsson

6

object named as

Håkan Emanuelsson

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Christopher P Cannon

1

object named as

Christopher P Cannon

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

8

object named as

Hugo Katus

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Richard C Becker

5

object named as

Richard C Becker

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

3

object named as

Stefan James

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

7

object named as

Steen Husted

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

15

object named as

Daniel Wojdyla

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Nardev S. Khurmi

10

object named as

Nardev S Khurmi

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Diego Ardissino

4

object named as

Diego Ardissino

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

9

object named as

Matyas Keltai

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Frederic Kontny

11

object named as

Frederic Kontny

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Basil S Lewis

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PLATelet inhibition and patient Outcomes Investigators

17

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

13 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

375

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

9711

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

283-293

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myoc

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Prasugrel versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of and inhospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardial infarction: results from Can Rapid risk stratification of Unstable angina patie

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) tria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical end points in coronary stent trials: a case for standardized definitions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of fondaparinux and enoxaparin in acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Bivalirudin during primary PCI in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Ticagrelor binds to human P2Y(12) independently from ADP but antagonizes ADP-induced receptor signaling and platelet aggregation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical implications of percutaneous coronary intervention-clopidogrel in unstable angina to prevent recurrent events (PCI-CURE) study: a US perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2962191-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(09)62191-7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34093139&oldid=1744016050"